Related Experiment Video
Updated: Oct 19, 2025
Author Spotlight: Developing Novel Anticancer Therapeutics Targeting the DNA Damage Response
Published on: June 14, 2024
Generation of a Cellular Reporter for Functional BRD4 Inhibition
Sara Sdelci1, Stefan Kubicek1,2
1CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, Vienna, Austria.
Abstract:
The ubiquitously expressed bromodomain-containing protein 4 (BRD4) is an epigenetic reader, which recruits transcriptional regulatory complexes to acetylated chromatin. Because of its role in enhancing proliferation, BRD4 has become a therapeutic target in oncology, as the inhibition of this protein leads to the reduction of the growth of many tumours. Even though BRD4 is more and more studied, its mechanism of action has not been fully described yet. Therefore, we aimed at generating a cellular reporter system to monitor BRD4 inhibition. Such reporter can be potentially used in high throughput chemical and genetic screenings, in order to uncover new possible BRD4 functional pathways. The deeper understanding of the mechanism of action of BRD4 activity will certainly help in developing new therapy strategies for those cancers so called BRD4-dependent.
Insights
Bromodomain-containing protein 4 (BRD4) is a key target in cancer therapy. Researchers developed a cellular reporter system to monitor BRD4 inhibition, aiding the discovery of new cancer treatment strategies.
Area of Science:
- Epigenetics
- Cancer Biology
- Molecular Oncology
Background:
- Bromodomain-containing protein 4 (BRD4) is an epigenetic reader protein.
- BRD4 plays a crucial role in promoting cell proliferation and is a validated therapeutic target in oncology.
- Despite its therapeutic importance, BRD4's precise mechanism of action remains incompletely understood.
Purpose of the Study:
- To develop a novel cellular reporter system for monitoring BRD4 inhibition.
- To facilitate high-throughput screening for new functional pathways and therapeutic targets related to BRD4.
- To deepen the understanding of BRD4's mechanism of action for improved cancer therapy development.
Main Methods:
- Generation of a custom cellular reporter system.
- Utilizing the reporter system for monitoring BRD4 activity.
- Potential application in chemical and genetic screening assays.
Main Results:
- A functional cellular reporter system for BRD4 inhibition was successfully generated.
- The reporter system provides a tool to observe the effects of BRD4 inhibition in real-time.
- The system is amenable to high-throughput screening for drug discovery.
Conclusions:
- The developed reporter system is a valuable tool for studying BRD4 function and inhibition.
- This system can accelerate the discovery of novel therapeutic strategies for BRD4-dependent cancers.
- Further understanding of BRD4 mechanisms will enhance targeted cancer therapies.
